Brain Implants Comprehensive Study by Type (Deep brain stimulator (DBS), Spinal cord stimulator (SCS), Vagus nerve stimulator (VNS)), Application (Hospitals, Clinics, Healthcare Facilities, Others), Disease (Chronic Pain, Epilepsy, Parkinson’s disease, Depression, Essential tremor, Alzheimer’s disease) Players and Region - Global Market Outlook to 2027

Brain Implants Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Increased Prevalence of Neurological Disorders Like Alzheimer’s disease, The Rise in Geriatric Population and Rapid Advancements in Medical Science are the key factors driving the global brain implant market. Brain implants are the neural implants that directly connected to the brain. These implants electrically stimulate, block or record the signals from the brain. It enables communication between the brain and electronic devices, thus permitting brain activity to be modified, recorded or translated. The purpose of these implants is establishing a biomedical prosthesis circumventing areas in the brain that have become dysfunctional after a stroke or other head injuries. However, the High Cost of Implant Installation may hinder the market growth.This growth is primarily driven by Increased Prevalence of Neurological Disorders Like Alzheimer’s disease .

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Volume UnitK Units
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Equipment sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Boston Scientific Corporation (United States), St Jude Medical (United States), Medtronic (Ireland), Pixium Vision (France), Neuralink (United States), Aleva Neurotherapeutics SA (Switzerland), Nevro Corporation (United States), NeuroPace Inc. (United States), NDI Medical LLC (United States) and Thermo Fisher Scientific Inc. (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

On 24th January 2019, Boston Scientific Corporation has launched the Vercise Primary Cell and Vercise Gevia, Deep Brain Stimulations (DBS) with directional leads. These new systems are approved by the United States Food and Drug Administration (FDA). These systems designed to allow physicians to control the range, shape, position and direction of electrical stimulation to treat symptoms of Parkinson’s disease.

Influencing Trend:
Use of Robotic Assistance for Brain Transplant Surgery

Market Growth Drivers:
Increased Prevalence of Neurological Disorders Like Alzheimer’s disease, The Rise in Geriatric Population and Rapid Advancements in Medical Science

Challenges:
Brain Implants are Vulnerable to Cyber Attacks and Legal Issues and Regulations

Restraints:
Unavailability of Treatment and High Cost of the Implant Installation

Opportunities:
Increasing Healthcare Awareness and Technological Advancement, Growth in the Healthcare Sector and Increased Research and Development Activities

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Brain Implants Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Brain Implants Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Brain Implants players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Brain Implants Study Sheds Light on
— The Brain Implants Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Brain Implants industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Brain Implants industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Deep brain stimulator (DBS)
  • Spinal cord stimulator (SCS)
  • Vagus nerve stimulator (VNS)
By Application
  • Hospitals
  • Clinics
  • Healthcare Facilities
  • Others
By Disease
  • Chronic Pain
  • Epilepsy
  • Parkinson’s disease
  • Depression
  • Essential tremor
  • Alzheimer’s disease

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Neurological Disorders Like Alzheimer’s disease
      • 3.2.2. The Rise in Geriatric Population
      • 3.2.3. Rapid Advancements in Medical Science
    • 3.3. Market Challenges
      • 3.3.1. Brain Implants are Vulnerable to Cyber Attacks
      • 3.3.2. Legal Issues and Regulations
    • 3.4. Market Trends
      • 3.4.1. Use of Robotic Assistance for Brain Transplant Surgery
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Brain Implants, by Type, Application, Disease and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Brain Implants (Value)
      • 5.2.1. Global Brain Implants by: Type (Value)
        • 5.2.1.1. Deep brain stimulator (DBS)
        • 5.2.1.2. Spinal cord stimulator (SCS)
        • 5.2.1.3. Vagus nerve stimulator (VNS)
      • 5.2.2. Global Brain Implants by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Healthcare Facilities
        • 5.2.2.4. Others
      • 5.2.3. Global Brain Implants by: Disease (Value)
        • 5.2.3.1. Chronic Pain
        • 5.2.3.2. Epilepsy
        • 5.2.3.3. Parkinson’s disease
        • 5.2.3.4. Depression
        • 5.2.3.5. Essential tremor
        • 5.2.3.6. Alzheimer’s disease
      • 5.2.4. Global Brain Implants Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Brain Implants (Volume)
      • 5.3.1. Global Brain Implants by: Type (Volume)
        • 5.3.1.1. Deep brain stimulator (DBS)
        • 5.3.1.2. Spinal cord stimulator (SCS)
        • 5.3.1.3. Vagus nerve stimulator (VNS)
      • 5.3.2. Global Brain Implants by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Healthcare Facilities
        • 5.3.2.4. Others
      • 5.3.3. Global Brain Implants by: Disease (Volume)
        • 5.3.3.1. Chronic Pain
        • 5.3.3.2. Epilepsy
        • 5.3.3.3. Parkinson’s disease
        • 5.3.3.4. Depression
        • 5.3.3.5. Essential tremor
        • 5.3.3.6. Alzheimer’s disease
      • 5.3.4. Global Brain Implants Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Brain Implants (Price)
      • 5.4.1. Global Brain Implants by: Type (Price)
  • 6. Brain Implants: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boston Scientific Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. St Jude Medical (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pixium Vision (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Neuralink (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Aleva Neurotherapeutics SA (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nevro Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. NeuroPace Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. NDI Medical LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Thermo Fisher Scientific Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Brain Implants Sale, by Type, Application, Disease and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Brain Implants (Value)
      • 7.2.1. Global Brain Implants by: Type (Value)
        • 7.2.1.1. Deep brain stimulator (DBS)
        • 7.2.1.2. Spinal cord stimulator (SCS)
        • 7.2.1.3. Vagus nerve stimulator (VNS)
      • 7.2.2. Global Brain Implants by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Healthcare Facilities
        • 7.2.2.4. Others
      • 7.2.3. Global Brain Implants by: Disease (Value)
        • 7.2.3.1. Chronic Pain
        • 7.2.3.2. Epilepsy
        • 7.2.3.3. Parkinson’s disease
        • 7.2.3.4. Depression
        • 7.2.3.5. Essential tremor
        • 7.2.3.6. Alzheimer’s disease
      • 7.2.4. Global Brain Implants Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Brain Implants (Volume)
      • 7.3.1. Global Brain Implants by: Type (Volume)
        • 7.3.1.1. Deep brain stimulator (DBS)
        • 7.3.1.2. Spinal cord stimulator (SCS)
        • 7.3.1.3. Vagus nerve stimulator (VNS)
      • 7.3.2. Global Brain Implants by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Healthcare Facilities
        • 7.3.2.4. Others
      • 7.3.3. Global Brain Implants by: Disease (Volume)
        • 7.3.3.1. Chronic Pain
        • 7.3.3.2. Epilepsy
        • 7.3.3.3. Parkinson’s disease
        • 7.3.3.4. Depression
        • 7.3.3.5. Essential tremor
        • 7.3.3.6. Alzheimer’s disease
      • 7.3.4. Global Brain Implants Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Brain Implants (Price)
      • 7.4.1. Global Brain Implants by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Brain Implants: by Type(USD Million)
  • Table 2. Brain Implants Deep brain stimulator (DBS) , by Region USD Million (2016-2021)
  • Table 3. Brain Implants Spinal cord stimulator (SCS) , by Region USD Million (2016-2021)
  • Table 4. Brain Implants Vagus nerve stimulator (VNS) , by Region USD Million (2016-2021)
  • Table 5. Brain Implants: by Application(USD Million)
  • Table 6. Brain Implants Hospitals , by Region USD Million (2016-2021)
  • Table 7. Brain Implants Clinics , by Region USD Million (2016-2021)
  • Table 8. Brain Implants Healthcare Facilities , by Region USD Million (2016-2021)
  • Table 9. Brain Implants Others , by Region USD Million (2016-2021)
  • Table 10. Brain Implants: by Disease(USD Million)
  • Table 11. Brain Implants Chronic Pain , by Region USD Million (2016-2021)
  • Table 12. Brain Implants Epilepsy , by Region USD Million (2016-2021)
  • Table 13. Brain Implants Parkinson’s disease , by Region USD Million (2016-2021)
  • Table 14. Brain Implants Depression , by Region USD Million (2016-2021)
  • Table 15. Brain Implants Essential tremor , by Region USD Million (2016-2021)
  • Table 16. Brain Implants Alzheimer’s disease , by Region USD Million (2016-2021)
  • Table 17. South America Brain Implants, by Country USD Million (2016-2021)
  • Table 18. South America Brain Implants, by Type USD Million (2016-2021)
  • Table 19. South America Brain Implants, by Application USD Million (2016-2021)
  • Table 20. South America Brain Implants, by Disease USD Million (2016-2021)
  • Table 21. Brazil Brain Implants, by Type USD Million (2016-2021)
  • Table 22. Brazil Brain Implants, by Application USD Million (2016-2021)
  • Table 23. Brazil Brain Implants, by Disease USD Million (2016-2021)
  • Table 24. Argentina Brain Implants, by Type USD Million (2016-2021)
  • Table 25. Argentina Brain Implants, by Application USD Million (2016-2021)
  • Table 26. Argentina Brain Implants, by Disease USD Million (2016-2021)
  • Table 27. Rest of South America Brain Implants, by Type USD Million (2016-2021)
  • Table 28. Rest of South America Brain Implants, by Application USD Million (2016-2021)
  • Table 29. Rest of South America Brain Implants, by Disease USD Million (2016-2021)
  • Table 30. Asia Pacific Brain Implants, by Country USD Million (2016-2021)
  • Table 31. Asia Pacific Brain Implants, by Type USD Million (2016-2021)
  • Table 32. Asia Pacific Brain Implants, by Application USD Million (2016-2021)
  • Table 33. Asia Pacific Brain Implants, by Disease USD Million (2016-2021)
  • Table 34. China Brain Implants, by Type USD Million (2016-2021)
  • Table 35. China Brain Implants, by Application USD Million (2016-2021)
  • Table 36. China Brain Implants, by Disease USD Million (2016-2021)
  • Table 37. Japan Brain Implants, by Type USD Million (2016-2021)
  • Table 38. Japan Brain Implants, by Application USD Million (2016-2021)
  • Table 39. Japan Brain Implants, by Disease USD Million (2016-2021)
  • Table 40. India Brain Implants, by Type USD Million (2016-2021)
  • Table 41. India Brain Implants, by Application USD Million (2016-2021)
  • Table 42. India Brain Implants, by Disease USD Million (2016-2021)
  • Table 43. South Korea Brain Implants, by Type USD Million (2016-2021)
  • Table 44. South Korea Brain Implants, by Application USD Million (2016-2021)
  • Table 45. South Korea Brain Implants, by Disease USD Million (2016-2021)
  • Table 46. Taiwan Brain Implants, by Type USD Million (2016-2021)
  • Table 47. Taiwan Brain Implants, by Application USD Million (2016-2021)
  • Table 48. Taiwan Brain Implants, by Disease USD Million (2016-2021)
  • Table 49. Australia Brain Implants, by Type USD Million (2016-2021)
  • Table 50. Australia Brain Implants, by Application USD Million (2016-2021)
  • Table 51. Australia Brain Implants, by Disease USD Million (2016-2021)
  • Table 52. Rest of Asia-Pacific Brain Implants, by Type USD Million (2016-2021)
  • Table 53. Rest of Asia-Pacific Brain Implants, by Application USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Brain Implants, by Disease USD Million (2016-2021)
  • Table 55. Europe Brain Implants, by Country USD Million (2016-2021)
  • Table 56. Europe Brain Implants, by Type USD Million (2016-2021)
  • Table 57. Europe Brain Implants, by Application USD Million (2016-2021)
  • Table 58. Europe Brain Implants, by Disease USD Million (2016-2021)
  • Table 59. Germany Brain Implants, by Type USD Million (2016-2021)
  • Table 60. Germany Brain Implants, by Application USD Million (2016-2021)
  • Table 61. Germany Brain Implants, by Disease USD Million (2016-2021)
  • Table 62. France Brain Implants, by Type USD Million (2016-2021)
  • Table 63. France Brain Implants, by Application USD Million (2016-2021)
  • Table 64. France Brain Implants, by Disease USD Million (2016-2021)
  • Table 65. Italy Brain Implants, by Type USD Million (2016-2021)
  • Table 66. Italy Brain Implants, by Application USD Million (2016-2021)
  • Table 67. Italy Brain Implants, by Disease USD Million (2016-2021)
  • Table 68. United Kingdom Brain Implants, by Type USD Million (2016-2021)
  • Table 69. United Kingdom Brain Implants, by Application USD Million (2016-2021)
  • Table 70. United Kingdom Brain Implants, by Disease USD Million (2016-2021)
  • Table 71. Netherlands Brain Implants, by Type USD Million (2016-2021)
  • Table 72. Netherlands Brain Implants, by Application USD Million (2016-2021)
  • Table 73. Netherlands Brain Implants, by Disease USD Million (2016-2021)
  • Table 74. Rest of Europe Brain Implants, by Type USD Million (2016-2021)
  • Table 75. Rest of Europe Brain Implants, by Application USD Million (2016-2021)
  • Table 76. Rest of Europe Brain Implants, by Disease USD Million (2016-2021)
  • Table 77. MEA Brain Implants, by Country USD Million (2016-2021)
  • Table 78. MEA Brain Implants, by Type USD Million (2016-2021)
  • Table 79. MEA Brain Implants, by Application USD Million (2016-2021)
  • Table 80. MEA Brain Implants, by Disease USD Million (2016-2021)
  • Table 81. Middle East Brain Implants, by Type USD Million (2016-2021)
  • Table 82. Middle East Brain Implants, by Application USD Million (2016-2021)
  • Table 83. Middle East Brain Implants, by Disease USD Million (2016-2021)
  • Table 84. Africa Brain Implants, by Type USD Million (2016-2021)
  • Table 85. Africa Brain Implants, by Application USD Million (2016-2021)
  • Table 86. Africa Brain Implants, by Disease USD Million (2016-2021)
  • Table 87. North America Brain Implants, by Country USD Million (2016-2021)
  • Table 88. North America Brain Implants, by Type USD Million (2016-2021)
  • Table 89. North America Brain Implants, by Application USD Million (2016-2021)
  • Table 90. North America Brain Implants, by Disease USD Million (2016-2021)
  • Table 91. United States Brain Implants, by Type USD Million (2016-2021)
  • Table 92. United States Brain Implants, by Application USD Million (2016-2021)
  • Table 93. United States Brain Implants, by Disease USD Million (2016-2021)
  • Table 94. Canada Brain Implants, by Type USD Million (2016-2021)
  • Table 95. Canada Brain Implants, by Application USD Million (2016-2021)
  • Table 96. Canada Brain Implants, by Disease USD Million (2016-2021)
  • Table 97. Mexico Brain Implants, by Type USD Million (2016-2021)
  • Table 98. Mexico Brain Implants, by Application USD Million (2016-2021)
  • Table 99. Mexico Brain Implants, by Disease USD Million (2016-2021)
  • Table 100. Brain Implants Sales: by Type(K Units)
  • Table 101. Brain Implants Sales Deep brain stimulator (DBS) , by Region K Units (2016-2021)
  • Table 102. Brain Implants Sales Spinal cord stimulator (SCS) , by Region K Units (2016-2021)
  • Table 103. Brain Implants Sales Vagus nerve stimulator (VNS) , by Region K Units (2016-2021)
  • Table 104. Brain Implants Sales: by Application(K Units)
  • Table 105. Brain Implants Sales Hospitals , by Region K Units (2016-2021)
  • Table 106. Brain Implants Sales Clinics , by Region K Units (2016-2021)
  • Table 107. Brain Implants Sales Healthcare Facilities , by Region K Units (2016-2021)
  • Table 108. Brain Implants Sales Others , by Region K Units (2016-2021)
  • Table 109. Brain Implants Sales: by Disease(K Units)
  • Table 110. Brain Implants Sales Chronic Pain , by Region K Units (2016-2021)
  • Table 111. Brain Implants Sales Epilepsy , by Region K Units (2016-2021)
  • Table 112. Brain Implants Sales Parkinson’s disease , by Region K Units (2016-2021)
  • Table 113. Brain Implants Sales Depression , by Region K Units (2016-2021)
  • Table 114. Brain Implants Sales Essential tremor , by Region K Units (2016-2021)
  • Table 115. Brain Implants Sales Alzheimer’s disease , by Region K Units (2016-2021)
  • Table 116. South America Brain Implants Sales, by Country K Units (2016-2021)
  • Table 117. South America Brain Implants Sales, by Type K Units (2016-2021)
  • Table 118. South America Brain Implants Sales, by Application K Units (2016-2021)
  • Table 119. South America Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 120. Brazil Brain Implants Sales, by Type K Units (2016-2021)
  • Table 121. Brazil Brain Implants Sales, by Application K Units (2016-2021)
  • Table 122. Brazil Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 123. Argentina Brain Implants Sales, by Type K Units (2016-2021)
  • Table 124. Argentina Brain Implants Sales, by Application K Units (2016-2021)
  • Table 125. Argentina Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 126. Rest of South America Brain Implants Sales, by Type K Units (2016-2021)
  • Table 127. Rest of South America Brain Implants Sales, by Application K Units (2016-2021)
  • Table 128. Rest of South America Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 129. Asia Pacific Brain Implants Sales, by Country K Units (2016-2021)
  • Table 130. Asia Pacific Brain Implants Sales, by Type K Units (2016-2021)
  • Table 131. Asia Pacific Brain Implants Sales, by Application K Units (2016-2021)
  • Table 132. Asia Pacific Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 133. China Brain Implants Sales, by Type K Units (2016-2021)
  • Table 134. China Brain Implants Sales, by Application K Units (2016-2021)
  • Table 135. China Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 136. Japan Brain Implants Sales, by Type K Units (2016-2021)
  • Table 137. Japan Brain Implants Sales, by Application K Units (2016-2021)
  • Table 138. Japan Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 139. India Brain Implants Sales, by Type K Units (2016-2021)
  • Table 140. India Brain Implants Sales, by Application K Units (2016-2021)
  • Table 141. India Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 142. South Korea Brain Implants Sales, by Type K Units (2016-2021)
  • Table 143. South Korea Brain Implants Sales, by Application K Units (2016-2021)
  • Table 144. South Korea Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 145. Taiwan Brain Implants Sales, by Type K Units (2016-2021)
  • Table 146. Taiwan Brain Implants Sales, by Application K Units (2016-2021)
  • Table 147. Taiwan Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 148. Australia Brain Implants Sales, by Type K Units (2016-2021)
  • Table 149. Australia Brain Implants Sales, by Application K Units (2016-2021)
  • Table 150. Australia Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 151. Rest of Asia-Pacific Brain Implants Sales, by Type K Units (2016-2021)
  • Table 152. Rest of Asia-Pacific Brain Implants Sales, by Application K Units (2016-2021)
  • Table 153. Rest of Asia-Pacific Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 154. Europe Brain Implants Sales, by Country K Units (2016-2021)
  • Table 155. Europe Brain Implants Sales, by Type K Units (2016-2021)
  • Table 156. Europe Brain Implants Sales, by Application K Units (2016-2021)
  • Table 157. Europe Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 158. Germany Brain Implants Sales, by Type K Units (2016-2021)
  • Table 159. Germany Brain Implants Sales, by Application K Units (2016-2021)
  • Table 160. Germany Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 161. France Brain Implants Sales, by Type K Units (2016-2021)
  • Table 162. France Brain Implants Sales, by Application K Units (2016-2021)
  • Table 163. France Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 164. Italy Brain Implants Sales, by Type K Units (2016-2021)
  • Table 165. Italy Brain Implants Sales, by Application K Units (2016-2021)
  • Table 166. Italy Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 167. United Kingdom Brain Implants Sales, by Type K Units (2016-2021)
  • Table 168. United Kingdom Brain Implants Sales, by Application K Units (2016-2021)
  • Table 169. United Kingdom Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 170. Netherlands Brain Implants Sales, by Type K Units (2016-2021)
  • Table 171. Netherlands Brain Implants Sales, by Application K Units (2016-2021)
  • Table 172. Netherlands Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 173. Rest of Europe Brain Implants Sales, by Type K Units (2016-2021)
  • Table 174. Rest of Europe Brain Implants Sales, by Application K Units (2016-2021)
  • Table 175. Rest of Europe Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 176. MEA Brain Implants Sales, by Country K Units (2016-2021)
  • Table 177. MEA Brain Implants Sales, by Type K Units (2016-2021)
  • Table 178. MEA Brain Implants Sales, by Application K Units (2016-2021)
  • Table 179. MEA Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 180. Middle East Brain Implants Sales, by Type K Units (2016-2021)
  • Table 181. Middle East Brain Implants Sales, by Application K Units (2016-2021)
  • Table 182. Middle East Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 183. Africa Brain Implants Sales, by Type K Units (2016-2021)
  • Table 184. Africa Brain Implants Sales, by Application K Units (2016-2021)
  • Table 185. Africa Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 186. North America Brain Implants Sales, by Country K Units (2016-2021)
  • Table 187. North America Brain Implants Sales, by Type K Units (2016-2021)
  • Table 188. North America Brain Implants Sales, by Application K Units (2016-2021)
  • Table 189. North America Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 190. United States Brain Implants Sales, by Type K Units (2016-2021)
  • Table 191. United States Brain Implants Sales, by Application K Units (2016-2021)
  • Table 192. United States Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 193. Canada Brain Implants Sales, by Type K Units (2016-2021)
  • Table 194. Canada Brain Implants Sales, by Application K Units (2016-2021)
  • Table 195. Canada Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 196. Mexico Brain Implants Sales, by Type K Units (2016-2021)
  • Table 197. Mexico Brain Implants Sales, by Application K Units (2016-2021)
  • Table 198. Mexico Brain Implants Sales, by Disease K Units (2016-2021)
  • Table 199. Brain Implants: by Type(USD/Units)
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Brain Implants: by Type(USD Million)
  • Table 211. Brain Implants Deep brain stimulator (DBS) , by Region USD Million (2022-2027)
  • Table 212. Brain Implants Spinal cord stimulator (SCS) , by Region USD Million (2022-2027)
  • Table 213. Brain Implants Vagus nerve stimulator (VNS) , by Region USD Million (2022-2027)
  • Table 214. Brain Implants: by Application(USD Million)
  • Table 215. Brain Implants Hospitals , by Region USD Million (2022-2027)
  • Table 216. Brain Implants Clinics , by Region USD Million (2022-2027)
  • Table 217. Brain Implants Healthcare Facilities , by Region USD Million (2022-2027)
  • Table 218. Brain Implants Others , by Region USD Million (2022-2027)
  • Table 219. Brain Implants: by Disease(USD Million)
  • Table 220. Brain Implants Chronic Pain , by Region USD Million (2022-2027)
  • Table 221. Brain Implants Epilepsy , by Region USD Million (2022-2027)
  • Table 222. Brain Implants Parkinson’s disease , by Region USD Million (2022-2027)
  • Table 223. Brain Implants Depression , by Region USD Million (2022-2027)
  • Table 224. Brain Implants Essential tremor , by Region USD Million (2022-2027)
  • Table 225. Brain Implants Alzheimer’s disease , by Region USD Million (2022-2027)
  • Table 226. South America Brain Implants, by Country USD Million (2022-2027)
  • Table 227. South America Brain Implants, by Type USD Million (2022-2027)
  • Table 228. South America Brain Implants, by Application USD Million (2022-2027)
  • Table 229. South America Brain Implants, by Disease USD Million (2022-2027)
  • Table 230. Brazil Brain Implants, by Type USD Million (2022-2027)
  • Table 231. Brazil Brain Implants, by Application USD Million (2022-2027)
  • Table 232. Brazil Brain Implants, by Disease USD Million (2022-2027)
  • Table 233. Argentina Brain Implants, by Type USD Million (2022-2027)
  • Table 234. Argentina Brain Implants, by Application USD Million (2022-2027)
  • Table 235. Argentina Brain Implants, by Disease USD Million (2022-2027)
  • Table 236. Rest of South America Brain Implants, by Type USD Million (2022-2027)
  • Table 237. Rest of South America Brain Implants, by Application USD Million (2022-2027)
  • Table 238. Rest of South America Brain Implants, by Disease USD Million (2022-2027)
  • Table 239. Asia Pacific Brain Implants, by Country USD Million (2022-2027)
  • Table 240. Asia Pacific Brain Implants, by Type USD Million (2022-2027)
  • Table 241. Asia Pacific Brain Implants, by Application USD Million (2022-2027)
  • Table 242. Asia Pacific Brain Implants, by Disease USD Million (2022-2027)
  • Table 243. China Brain Implants, by Type USD Million (2022-2027)
  • Table 244. China Brain Implants, by Application USD Million (2022-2027)
  • Table 245. China Brain Implants, by Disease USD Million (2022-2027)
  • Table 246. Japan Brain Implants, by Type USD Million (2022-2027)
  • Table 247. Japan Brain Implants, by Application USD Million (2022-2027)
  • Table 248. Japan Brain Implants, by Disease USD Million (2022-2027)
  • Table 249. India Brain Implants, by Type USD Million (2022-2027)
  • Table 250. India Brain Implants, by Application USD Million (2022-2027)
  • Table 251. India Brain Implants, by Disease USD Million (2022-2027)
  • Table 252. South Korea Brain Implants, by Type USD Million (2022-2027)
  • Table 253. South Korea Brain Implants, by Application USD Million (2022-2027)
  • Table 254. South Korea Brain Implants, by Disease USD Million (2022-2027)
  • Table 255. Taiwan Brain Implants, by Type USD Million (2022-2027)
  • Table 256. Taiwan Brain Implants, by Application USD Million (2022-2027)
  • Table 257. Taiwan Brain Implants, by Disease USD Million (2022-2027)
  • Table 258. Australia Brain Implants, by Type USD Million (2022-2027)
  • Table 259. Australia Brain Implants, by Application USD Million (2022-2027)
  • Table 260. Australia Brain Implants, by Disease USD Million (2022-2027)
  • Table 261. Rest of Asia-Pacific Brain Implants, by Type USD Million (2022-2027)
  • Table 262. Rest of Asia-Pacific Brain Implants, by Application USD Million (2022-2027)
  • Table 263. Rest of Asia-Pacific Brain Implants, by Disease USD Million (2022-2027)
  • Table 264. Europe Brain Implants, by Country USD Million (2022-2027)
  • Table 265. Europe Brain Implants, by Type USD Million (2022-2027)
  • Table 266. Europe Brain Implants, by Application USD Million (2022-2027)
  • Table 267. Europe Brain Implants, by Disease USD Million (2022-2027)
  • Table 268. Germany Brain Implants, by Type USD Million (2022-2027)
  • Table 269. Germany Brain Implants, by Application USD Million (2022-2027)
  • Table 270. Germany Brain Implants, by Disease USD Million (2022-2027)
  • Table 271. France Brain Implants, by Type USD Million (2022-2027)
  • Table 272. France Brain Implants, by Application USD Million (2022-2027)
  • Table 273. France Brain Implants, by Disease USD Million (2022-2027)
  • Table 274. Italy Brain Implants, by Type USD Million (2022-2027)
  • Table 275. Italy Brain Implants, by Application USD Million (2022-2027)
  • Table 276. Italy Brain Implants, by Disease USD Million (2022-2027)
  • Table 277. United Kingdom Brain Implants, by Type USD Million (2022-2027)
  • Table 278. United Kingdom Brain Implants, by Application USD Million (2022-2027)
  • Table 279. United Kingdom Brain Implants, by Disease USD Million (2022-2027)
  • Table 280. Netherlands Brain Implants, by Type USD Million (2022-2027)
  • Table 281. Netherlands Brain Implants, by Application USD Million (2022-2027)
  • Table 282. Netherlands Brain Implants, by Disease USD Million (2022-2027)
  • Table 283. Rest of Europe Brain Implants, by Type USD Million (2022-2027)
  • Table 284. Rest of Europe Brain Implants, by Application USD Million (2022-2027)
  • Table 285. Rest of Europe Brain Implants, by Disease USD Million (2022-2027)
  • Table 286. MEA Brain Implants, by Country USD Million (2022-2027)
  • Table 287. MEA Brain Implants, by Type USD Million (2022-2027)
  • Table 288. MEA Brain Implants, by Application USD Million (2022-2027)
  • Table 289. MEA Brain Implants, by Disease USD Million (2022-2027)
  • Table 290. Middle East Brain Implants, by Type USD Million (2022-2027)
  • Table 291. Middle East Brain Implants, by Application USD Million (2022-2027)
  • Table 292. Middle East Brain Implants, by Disease USD Million (2022-2027)
  • Table 293. Africa Brain Implants, by Type USD Million (2022-2027)
  • Table 294. Africa Brain Implants, by Application USD Million (2022-2027)
  • Table 295. Africa Brain Implants, by Disease USD Million (2022-2027)
  • Table 296. North America Brain Implants, by Country USD Million (2022-2027)
  • Table 297. North America Brain Implants, by Type USD Million (2022-2027)
  • Table 298. North America Brain Implants, by Application USD Million (2022-2027)
  • Table 299. North America Brain Implants, by Disease USD Million (2022-2027)
  • Table 300. United States Brain Implants, by Type USD Million (2022-2027)
  • Table 301. United States Brain Implants, by Application USD Million (2022-2027)
  • Table 302. United States Brain Implants, by Disease USD Million (2022-2027)
  • Table 303. Canada Brain Implants, by Type USD Million (2022-2027)
  • Table 304. Canada Brain Implants, by Application USD Million (2022-2027)
  • Table 305. Canada Brain Implants, by Disease USD Million (2022-2027)
  • Table 306. Mexico Brain Implants, by Type USD Million (2022-2027)
  • Table 307. Mexico Brain Implants, by Application USD Million (2022-2027)
  • Table 308. Mexico Brain Implants, by Disease USD Million (2022-2027)
  • Table 309. Brain Implants Sales: by Type(K Units)
  • Table 310. Brain Implants Sales Deep brain stimulator (DBS) , by Region K Units (2022-2027)
  • Table 311. Brain Implants Sales Spinal cord stimulator (SCS) , by Region K Units (2022-2027)
  • Table 312. Brain Implants Sales Vagus nerve stimulator (VNS) , by Region K Units (2022-2027)
  • Table 313. Brain Implants Sales: by Application(K Units)
  • Table 314. Brain Implants Sales Hospitals , by Region K Units (2022-2027)
  • Table 315. Brain Implants Sales Clinics , by Region K Units (2022-2027)
  • Table 316. Brain Implants Sales Healthcare Facilities , by Region K Units (2022-2027)
  • Table 317. Brain Implants Sales Others , by Region K Units (2022-2027)
  • Table 318. Brain Implants Sales: by Disease(K Units)
  • Table 319. Brain Implants Sales Chronic Pain , by Region K Units (2022-2027)
  • Table 320. Brain Implants Sales Epilepsy , by Region K Units (2022-2027)
  • Table 321. Brain Implants Sales Parkinson’s disease , by Region K Units (2022-2027)
  • Table 322. Brain Implants Sales Depression , by Region K Units (2022-2027)
  • Table 323. Brain Implants Sales Essential tremor , by Region K Units (2022-2027)
  • Table 324. Brain Implants Sales Alzheimer’s disease , by Region K Units (2022-2027)
  • Table 325. South America Brain Implants Sales, by Country K Units (2022-2027)
  • Table 326. South America Brain Implants Sales, by Type K Units (2022-2027)
  • Table 327. South America Brain Implants Sales, by Application K Units (2022-2027)
  • Table 328. South America Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 329. Brazil Brain Implants Sales, by Type K Units (2022-2027)
  • Table 330. Brazil Brain Implants Sales, by Application K Units (2022-2027)
  • Table 331. Brazil Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 332. Argentina Brain Implants Sales, by Type K Units (2022-2027)
  • Table 333. Argentina Brain Implants Sales, by Application K Units (2022-2027)
  • Table 334. Argentina Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 335. Rest of South America Brain Implants Sales, by Type K Units (2022-2027)
  • Table 336. Rest of South America Brain Implants Sales, by Application K Units (2022-2027)
  • Table 337. Rest of South America Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 338. Asia Pacific Brain Implants Sales, by Country K Units (2022-2027)
  • Table 339. Asia Pacific Brain Implants Sales, by Type K Units (2022-2027)
  • Table 340. Asia Pacific Brain Implants Sales, by Application K Units (2022-2027)
  • Table 341. Asia Pacific Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 342. China Brain Implants Sales, by Type K Units (2022-2027)
  • Table 343. China Brain Implants Sales, by Application K Units (2022-2027)
  • Table 344. China Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 345. Japan Brain Implants Sales, by Type K Units (2022-2027)
  • Table 346. Japan Brain Implants Sales, by Application K Units (2022-2027)
  • Table 347. Japan Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 348. India Brain Implants Sales, by Type K Units (2022-2027)
  • Table 349. India Brain Implants Sales, by Application K Units (2022-2027)
  • Table 350. India Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 351. South Korea Brain Implants Sales, by Type K Units (2022-2027)
  • Table 352. South Korea Brain Implants Sales, by Application K Units (2022-2027)
  • Table 353. South Korea Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 354. Taiwan Brain Implants Sales, by Type K Units (2022-2027)
  • Table 355. Taiwan Brain Implants Sales, by Application K Units (2022-2027)
  • Table 356. Taiwan Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 357. Australia Brain Implants Sales, by Type K Units (2022-2027)
  • Table 358. Australia Brain Implants Sales, by Application K Units (2022-2027)
  • Table 359. Australia Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 360. Rest of Asia-Pacific Brain Implants Sales, by Type K Units (2022-2027)
  • Table 361. Rest of Asia-Pacific Brain Implants Sales, by Application K Units (2022-2027)
  • Table 362. Rest of Asia-Pacific Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 363. Europe Brain Implants Sales, by Country K Units (2022-2027)
  • Table 364. Europe Brain Implants Sales, by Type K Units (2022-2027)
  • Table 365. Europe Brain Implants Sales, by Application K Units (2022-2027)
  • Table 366. Europe Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 367. Germany Brain Implants Sales, by Type K Units (2022-2027)
  • Table 368. Germany Brain Implants Sales, by Application K Units (2022-2027)
  • Table 369. Germany Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 370. France Brain Implants Sales, by Type K Units (2022-2027)
  • Table 371. France Brain Implants Sales, by Application K Units (2022-2027)
  • Table 372. France Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 373. Italy Brain Implants Sales, by Type K Units (2022-2027)
  • Table 374. Italy Brain Implants Sales, by Application K Units (2022-2027)
  • Table 375. Italy Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 376. United Kingdom Brain Implants Sales, by Type K Units (2022-2027)
  • Table 377. United Kingdom Brain Implants Sales, by Application K Units (2022-2027)
  • Table 378. United Kingdom Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 379. Netherlands Brain Implants Sales, by Type K Units (2022-2027)
  • Table 380. Netherlands Brain Implants Sales, by Application K Units (2022-2027)
  • Table 381. Netherlands Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 382. Rest of Europe Brain Implants Sales, by Type K Units (2022-2027)
  • Table 383. Rest of Europe Brain Implants Sales, by Application K Units (2022-2027)
  • Table 384. Rest of Europe Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 385. MEA Brain Implants Sales, by Country K Units (2022-2027)
  • Table 386. MEA Brain Implants Sales, by Type K Units (2022-2027)
  • Table 387. MEA Brain Implants Sales, by Application K Units (2022-2027)
  • Table 388. MEA Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 389. Middle East Brain Implants Sales, by Type K Units (2022-2027)
  • Table 390. Middle East Brain Implants Sales, by Application K Units (2022-2027)
  • Table 391. Middle East Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 392. Africa Brain Implants Sales, by Type K Units (2022-2027)
  • Table 393. Africa Brain Implants Sales, by Application K Units (2022-2027)
  • Table 394. Africa Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 395. North America Brain Implants Sales, by Country K Units (2022-2027)
  • Table 396. North America Brain Implants Sales, by Type K Units (2022-2027)
  • Table 397. North America Brain Implants Sales, by Application K Units (2022-2027)
  • Table 398. North America Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 399. United States Brain Implants Sales, by Type K Units (2022-2027)
  • Table 400. United States Brain Implants Sales, by Application K Units (2022-2027)
  • Table 401. United States Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 402. Canada Brain Implants Sales, by Type K Units (2022-2027)
  • Table 403. Canada Brain Implants Sales, by Application K Units (2022-2027)
  • Table 404. Canada Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 405. Mexico Brain Implants Sales, by Type K Units (2022-2027)
  • Table 406. Mexico Brain Implants Sales, by Application K Units (2022-2027)
  • Table 407. Mexico Brain Implants Sales, by Disease K Units (2022-2027)
  • Table 408. Brain Implants: by Type(USD/Units)
  • Table 409. Research Programs/Design for This Report
  • Table 410. Key Data Information from Secondary Sources
  • Table 411. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Brain Implants: by Type USD Million (2016-2021)
  • Figure 5. Global Brain Implants: by Application USD Million (2016-2021)
  • Figure 6. Global Brain Implants: by Disease USD Million (2016-2021)
  • Figure 7. South America Brain Implants Share (%), by Country
  • Figure 8. Asia Pacific Brain Implants Share (%), by Country
  • Figure 9. Europe Brain Implants Share (%), by Country
  • Figure 10. MEA Brain Implants Share (%), by Country
  • Figure 11. North America Brain Implants Share (%), by Country
  • Figure 12. Global Brain Implants: by Type K Units (2016-2021)
  • Figure 13. Global Brain Implants: by Application K Units (2016-2021)
  • Figure 14. Global Brain Implants: by Disease K Units (2016-2021)
  • Figure 15. South America Brain Implants Share (%), by Country
  • Figure 16. Asia Pacific Brain Implants Share (%), by Country
  • Figure 17. Europe Brain Implants Share (%), by Country
  • Figure 18. MEA Brain Implants Share (%), by Country
  • Figure 19. North America Brain Implants Share (%), by Country
  • Figure 20. Global Brain Implants: by Type USD/Units (2016-2021)
  • Figure 21. Global Brain Implants share by Players 2021 (%)
  • Figure 22. Global Brain Implants share by Players (Top 3) 2021(%)
  • Figure 23. Global Brain Implants share by Players (Top 5) 2021(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Boston Scientific Corporation (United States) Revenue: by Geography 2021
  • Figure 27. St Jude Medical (United States) Revenue, Net Income and Gross profit
  • Figure 28. St Jude Medical (United States) Revenue: by Geography 2021
  • Figure 29. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Medtronic (Ireland) Revenue: by Geography 2021
  • Figure 31. Pixium Vision (France) Revenue, Net Income and Gross profit
  • Figure 32. Pixium Vision (France) Revenue: by Geography 2021
  • Figure 33. Neuralink (United States) Revenue, Net Income and Gross profit
  • Figure 34. Neuralink (United States) Revenue: by Geography 2021
  • Figure 35. Aleva Neurotherapeutics SA (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Aleva Neurotherapeutics SA (Switzerland) Revenue: by Geography 2021
  • Figure 37. Nevro Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 38. Nevro Corporation (United States) Revenue: by Geography 2021
  • Figure 39. NeuroPace Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. NeuroPace Inc. (United States) Revenue: by Geography 2021
  • Figure 41. NDI Medical LLC (United States) Revenue, Net Income and Gross profit
  • Figure 42. NDI Medical LLC (United States) Revenue: by Geography 2021
  • Figure 43. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2021
  • Figure 45. Global Brain Implants: by Type USD Million (2022-2027)
  • Figure 46. Global Brain Implants: by Application USD Million (2022-2027)
  • Figure 47. Global Brain Implants: by Disease USD Million (2022-2027)
  • Figure 48. South America Brain Implants Share (%), by Country
  • Figure 49. Asia Pacific Brain Implants Share (%), by Country
  • Figure 50. Europe Brain Implants Share (%), by Country
  • Figure 51. MEA Brain Implants Share (%), by Country
  • Figure 52. North America Brain Implants Share (%), by Country
  • Figure 53. Global Brain Implants: by Type K Units (2022-2027)
  • Figure 54. Global Brain Implants: by Application K Units (2022-2027)
  • Figure 55. Global Brain Implants: by Disease K Units (2022-2027)
  • Figure 56. South America Brain Implants Share (%), by Country
  • Figure 57. Asia Pacific Brain Implants Share (%), by Country
  • Figure 58. Europe Brain Implants Share (%), by Country
  • Figure 59. MEA Brain Implants Share (%), by Country
  • Figure 60. North America Brain Implants Share (%), by Country
  • Figure 61. Global Brain Implants: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Boston Scientific Corporation (United States)
  • St Jude Medical (United States)
  • Medtronic (Ireland)
  • Pixium Vision (France)
  • Neuralink (United States)
  • Aleva Neurotherapeutics SA (Switzerland)
  • Nevro Corporation (United States)
  • NeuroPace Inc. (United States)
  • NDI Medical LLC (United States)
  • Thermo Fisher Scientific Inc. (United States)
Additional players considered in the study are as follows:
Terumo Corporation (Japan) , Sapiens Steering Brain Stimulation (Germany)
Select User Access Type

Key Highlights of Report


Nov 2023 241 Pages 82 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Brain Implants Market are Boston Scientific Corporation (United States), St Jude Medical (United States), Medtronic (Ireland), Pixium Vision (France), Neuralink (United States), Aleva Neurotherapeutics SA (Switzerland), Nevro Corporation (United States), NeuroPace Inc. (United States), NDI Medical LLC (United States) and Thermo Fisher Scientific Inc. (United States) etc.
Hospitals segment in Global market to hold robust market share owing to "Increased Prevalence of Neurological Disorders Like Alzheimer’s disease ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Brain Implants market throughout the forecasted period.

Know More About Brain Implants Report?